Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
$63.47
+5.9%
$42.16
$14.27
$64.00
$1.81B0.86674,147 shs640,054 shs
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
$1.34
+8.1%
$2.99
$0.15
$1.27
$61.85M-0.4314.23 million shs28,860 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
0.00%+7.83%+43.79%+94.75%+283.50%
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
0.00%0.00%0.00%0.00%-29.47%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
$63.47
+5.9%
$42.16
$14.27
$64.00
$1.81B0.86674,147 shs640,054 shs
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
$1.34
+8.1%
$2.99
$0.15
$1.27
$61.85M-0.4314.23 million shs28,860 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
0.00%+7.83%+43.79%+94.75%+283.50%
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
0.00%0.00%0.00%0.00%-29.47%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
2.33
Hold$67.506.35% Upside
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest RTTR and ETON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
Boost Price TargetBuy$60.00 ➝ $68.00
8/14/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
Reiterated RatingBuy$40.00 ➝ $70.00
8/14/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
Boost Price TargetBuy$65.00 ➝ $70.00
8/11/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
Boost Price TargetBuy$57.00 ➝ $65.00
7/28/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
Boost Price TargetBuy$40.00 ➝ $62.00
7/17/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
Reiterated RatingSell (D-)
7/16/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
Initiated CoverageBuy$60.00
7/16/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
UpgradeStrong-Buy
7/13/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
DowngradeHoldStrong Sell
(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
$79.95M22.69N/AN/A$0.98 per share64.77
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
N/AN/AN/AN/A$0.10 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
-$4.60M$0.38167.0338.94N/A12.02%40.13%12.37%11/5/2026 (Estimated)
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
-$10.13MN/AN/AN/AN/AN/AN/A-162.05%N/A

Latest RTTR and ETON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
$0.1898$0.43+$0.2402$0.35$27.11 million$37.59 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
N/AN/AN/AN/AN/A
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
0.41
1.52
1.30
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
N/A
3.67
3.67

Institutional Ownership

CompanyInstitutional Ownership
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
27.86%
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
0.84%

Insider Ownership

CompanyInsider Ownership
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
16.49%
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
15.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
2028.58 million23.87 millionOptionable
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
746.15 millionN/ANot Optionable

Recent News About These Companies

John Ritter Biography & Movies
Jeff Ritter
Dr. John D. Ritter
German chocolate war ends with Ritter Sport victory
Kristen Ritter
Dr. Harold K. Ritter
Denver Business Journal welcomes new tech reporter
Gary W. Ritter, Ph.D.
Ritter Public Library in Vermilion adds book club

New MarketBeat Followers Over Time

Media Sentiment Over Time

Eton Pharmaceuticals stock logo

Eton Pharmaceuticals NASDAQ:ETON

$63.47 +3.56 (+5.94%)
As of 08/21/2026 04:00 PM Eastern

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Ritter Pharmaceuticals stock logo

Ritter Pharmaceuticals NASDAQ:RTTR

Ritter Pharmaceuticals, Inc. develops and sells novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which has completed Phase 2b clinical trial for the reduction of symptoms associated with lactose intolerance. The company's product, RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.